Inspire Medical Systems, Inc.
INSP· NYSE
Filed Feb 26, 2019 · 10-K · 57 days after period end · 0001609550-19-000013
| Metric | Q4 2018 | Q4 2017 |
|---|---|---|
| Revenue | $16.56M | $9.96M |
| Net Income | -$4.78M | -$4.25M |
| EPS Diluted | -$0.22 | -$3.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Feb 26, 2019 · 57 d after period end